• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX (TRIVASCULAR) OVATION IX; AORTIC MAIN BODY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX (TRIVASCULAR) OVATION IX; AORTIC MAIN BODY Back to Search Results
Model Number TV-AB2680-J
Medical Device Problem Codes Improper or Incorrect Procedure or Method (2017); Insufficient Device Problem Information (3190)
Health Effect - Clinical Code Aneurysm (1708)
Date of Event 08/23/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The lot history records related to the subject device referenced in this complaint record were reviewed for potential contributing factors for the failure mode(s) described in this event.A review of the device quality records showed that the device(s) demonstrated compliance to established procedures and specifications at the time of manufacture.
 
Event or Problem Description
The patient was initially implanted with the ovation ix abdominal stent graft system to treat an abdominal aortic aneurysm (aaa).An intraoperative type ia endoleak was identified.The physician elected to balloon at the level of the sealing rings however, the endoleak remained.A decision was made to conclude the case and continue to monitor the patient.
 
Additional Manufacturer Narrative
Clinical assessment was completed based on the received medical records.The reported type ia endoleak was confirmed.A definitive root cause for the type ia endoleak could not be confirmed; however, the calcium noted at the first sealing ring limited good apposition.The procedure related harms for the event could not be determined.The report of an intraoperative type ia left untreated and secondary endovascular procedure to implant a bare metal stent was unconfirmed due to lack of the relevant medical information.This event is user related due to the physician left the endoleak untreated at the initial implant and the calcium noted at the first sealing ring limited the good apposition.The final patient status was reported being stable.The manufacturing lot evaluation confirmed all devices met specifications prior to release.The device remains implanted; therefore, no device evaluation was completed.No additional investigation of this reported event is planned; however, if additional information pertinent to the incident is obtained, a follow-up report will be submitted.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.Corrections: g1,2: contact office- name - updated.H6: result code ¿ remove 3233.H6: conclusion code ¿ remove 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVATION IX
Common Device Name
AORTIC MAIN BODY
Manufacturer (Section D)
ENDOLOGIX (TRIVASCULAR)
3910 brickway blvd
santa rosa CA 95403
MDR Report Key9092657
Report Number3008011247-2019-00145
Device Sequence Number19467233
Product Code MIH
UDI-Device IdentifierM701TVAB2680J1
UDI-Public+M701TVAB2680J1/$$3220729FS07231905E
Combination Product (Y/N)N
Initial Reporter StateKY
Initial Reporter CountryUS
PMA/510(K) Number
P120006
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/29/2022
Device Model NumberTV-AB2680-J
Device Catalogue NumberTV-AB2680-J
Device Lot NumberFS072319-05
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 08/26/2019
Supplement Date Received by Manufacturer08/26/2019
Initial Report FDA Received Date09/19/2019
Supplement Report FDA Received Date07/15/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
OVATION CUSTOM SEAL FILL POLYMER.; OVATION IX ILIAC LIMB (2).; OVATION CUSTOM SEAL FILL POLYMER; OVATION IX ILIAC LIMB (2)
Outcome Attributed to Adverse Event Other;
Patient Age88 YR
-
-